Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

Core Viewpoint - Emerging Growth Research maintains a Buy-Extended rating and a 12-month price target of $3.50 for Immuron Limited following the release of its first-half fiscal year 2026 operating results [1] Financial Performance - Immuron reported global revenue of AUD$4.2 million for the six months ended December 31, 2025, which is a 5% increase compared to the prior-year period [1]